USRE40546E1
(en)
*
|
1996-05-01 |
2008-10-21 |
Scarista, Ltd. |
1,3-Propane diol esters and ethers and methods for their use in drug delivery
|
MY118354A
(en)
*
|
1995-05-01 |
2004-10-30 |
Scarista Ltd |
1,3-propane diol derivatives as bioactive compounds
|
DE69633009T2
(de)
*
|
1995-05-01 |
2005-07-21 |
Scarista Ltd., Douglas |
Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen
|
US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6255347B1
(en)
|
1996-06-21 |
2001-07-03 |
Advanced Research And Technology Institute |
Methods and compositions comprising R-ibuprofen
|
AU5105598A
(en)
*
|
1996-11-12 |
1998-06-03 |
American Home Products Corporation |
Indene inhibitors of cox-2
|
US5869524A
(en)
*
|
1996-11-12 |
1999-02-09 |
American Home Products Corporation |
Indene inhibitors of COX-2
|
WO1998027972A2
(en)
*
|
1996-12-23 |
1998-07-02 |
Texas A & M University |
Anti-amyloidogenic agents
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
EP1053000B1
(en)
*
|
1998-02-13 |
2008-05-07 |
Nutramax Laboratories, Inc. |
Agents and methods for protection, treatment and repair of connective tissue
|
US7413759B2
(en)
*
|
1998-05-21 |
2008-08-19 |
Beech-Nut Nutrition Corporation |
Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
|
US7141266B2
(en)
*
|
1998-05-21 |
2006-11-28 |
Beech-Nut Nutrition Corporation |
Baby-food compositions enhancing visual acuity and methods therefor
|
US6579551B1
(en)
|
1998-05-21 |
2003-06-17 |
Beech-Nut Nutrition Corporation |
Baby-food compositions containing egg yolk and methods therefor
|
US6149964A
(en)
*
|
1998-05-21 |
2000-11-21 |
Beech-Nut Nutrition Corporation |
Egg yolk-containing baby food compositions and methods therefor
|
US6572871B1
(en)
*
|
1999-01-06 |
2003-06-03 |
W. Edward Church |
Pain treatment method and apparatus using heating wrap and analgesic cream
|
US20040073258A1
(en)
*
|
1999-01-06 |
2004-04-15 |
Church W. Edward |
Body tissue and skin treatment method using pulsing heating pad and topical cream
|
GB9901809D0
(en)
*
|
1999-01-27 |
1999-03-17 |
Scarista Limited |
Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
|
US7235583B1
(en)
*
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
US6426367B1
(en)
*
|
1999-09-09 |
2002-07-30 |
Efa Sciences Llc |
Methods for selectively occluding blood supplies to neoplasias
|
EP1284729A4
(en)
*
|
2000-04-13 |
2007-12-19 |
Mayo Foundation |
REDUCTION AGENTS OF A (BETA) 42
|
US20060004086A1
(en)
*
|
2000-04-13 |
2006-01-05 |
Mayo Foundation For Medical Education And Research |
Method of reducing Abeta42 and treating diseases
|
US6306842B1
(en)
*
|
2000-06-02 |
2001-10-23 |
Medinox, Inc. |
Protected forms of a combination of pharmacologically active agents and uses therefor
|
WO2001093680A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Medinox, Inc. |
Protected forms of a combination of pharmacologically active agents and uses therefor
|
US6927239B1
(en)
*
|
2000-08-02 |
2005-08-09 |
Pharmanutrients |
Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
|
US7208522B1
(en)
|
2000-08-02 |
2007-04-24 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of Syndrome X
|
US6838451B1
(en)
|
2000-08-02 |
2005-01-04 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of inflammation, osteoarthritis, and other degenerative joint diseases
|
WO2002009725A1
(en)
*
|
2000-08-02 |
2002-02-07 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of inflamation, osteoarthritis, and other degenerative joint diseases
|
EP1349554A2
(en)
*
|
2000-12-14 |
2003-10-08 |
Tufts University |
Compositions and methods for treating an arthritic condition
|
AU2002305099A1
(en)
*
|
2001-03-23 |
2002-10-08 |
Protarga, Inc. |
Fatty alcohol drug conjugates
|
AU2002303164A1
(en)
*
|
2001-03-23 |
2002-10-08 |
Protarga, Inc. |
Fatty amine drug conjugates
|
GB0111282D0
(en)
*
|
2001-05-09 |
2001-06-27 |
Laxdale Ltd |
Potentiation of therapeutic effects of fatty acids
|
JP3977162B2
(ja)
*
|
2002-06-21 |
2007-09-19 |
株式会社バンダイナムコゲームス |
キャラクタ情報管理装置、プログラム及び情報記憶媒体
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
|
AU2004311577A1
(en)
*
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
US20050154059A1
(en)
*
|
2004-01-13 |
2005-07-14 |
Cook Mark E. |
Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
|
WO2005092062A2
(en)
*
|
2004-03-19 |
2005-10-06 |
Myriad Genetics, Inc. |
Compounds for neurodegenerative disorders
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
EP1745180A1
(en)
*
|
2004-04-29 |
2007-01-24 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
WO2006055965A2
(en)
*
|
2004-11-19 |
2006-05-26 |
Martek Biosciences Corporation |
Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
|
US20090318394A1
(en)
*
|
2004-11-19 |
2009-12-24 |
Julie Nauroth |
Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
|
US7893106B2
(en)
*
|
2004-11-19 |
2011-02-22 |
Martek Biosciences, Corporation |
Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
|
JP2009502807A
(ja)
*
|
2005-07-22 |
2009-01-29 |
ミリアド ジェネティクス, インコーポレイテッド |
薬剤含有率の高い製剤および投与量形態
|
US20090320148A1
(en)
*
|
2006-01-31 |
2009-12-24 |
Martek Biosciences Corporation |
Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
JP2010519311A
(ja)
*
|
2007-02-20 |
2010-06-03 |
マーテック バイオサイエンシーズ コーポレーション |
長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法
|
WO2008153722A1
(en)
*
|
2007-05-22 |
2008-12-18 |
The Board Of Regents Of The University Of Texas System |
Post-translational regulation of catalytic activities of cytochrome p450 46a1 and uses thereof
|
WO2009086281A1
(en)
*
|
2007-12-21 |
2009-07-09 |
Martek Biosciences Corporation |
Method for preparation of oxylipins
|
US9085527B2
(en)
*
|
2008-07-08 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acylated salicylates and their uses
|
LT2315740T
(lt)
|
2008-07-08 |
2018-02-26 |
Catabasis Pharmaceuticals, Inc. |
Acetilinti riebalų rūgščių salicilatai ir jų panaudojimas
|
EP4137128A1
(en)
|
2008-09-02 |
2023-02-22 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and a statin, and methods of using same
|
US20110229565A1
(en)
*
|
2008-09-17 |
2011-09-22 |
Karp Jeffrey M |
Drug Delivery Composition Comprising a Self-Assembled Gelator
|
MX345226B
(es)
|
2008-10-29 |
2017-01-20 |
Ablynx Nv |
Formulaciones de moleculas de union a antigeno de dominio sencillo.
|
RU2553214C2
(ru)
|
2008-10-29 |
2015-06-10 |
Аблинкс Н.В. |
Способы очистки однодоменных антигенсвязывающих молекул
|
PT2395991E
(pt)
|
2009-02-10 |
2013-09-03 |
Amarin Pharmaceuticals Ie Ltd |
Utilização de éster etílico de ácido eicosapentaenóico para tratamento de hipertrigliceridemia
|
EP3791880A1
(en)
|
2009-04-29 |
2021-03-17 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical compositions comprising epa
|
LT3278665T
(lt)
|
2009-04-29 |
2020-12-10 |
Amarin Pharmaceuticals Ireland Limited |
Stabili farmacinė kompozicija ir jos panaudojimo būdai
|
ES2856959T3
(es)
|
2009-06-15 |
2021-09-28 |
Amarin Pharmaceuticals Ie Ltd |
Composiciones y métodos para el tratamiento del ictus en un sujeto en terapia simultánea con estatina
|
CN102724877B
(zh)
|
2009-09-01 |
2015-05-13 |
凯特贝希制药公司 |
脂肪酸烟酸缀合物及其用途
|
USRE46608E1
(en)
|
2009-09-01 |
2017-11-14 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid niacin conjugates and their uses
|
US20110064813A1
(en)
*
|
2009-09-16 |
2011-03-17 |
Charles Vaughn |
Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
|
RU2012116079A
(ru)
|
2009-09-23 |
2013-10-27 |
АМАРИН КОРПОРЕЙШН ПиЭлСи |
Фармацевтическая композиция, включающая омега-3 жирную кислоту и гидроксипроизводное статина и способы ее применения
|
CN104586859B
(zh)
*
|
2009-12-31 |
2017-12-05 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
TW201138832A
(en)
*
|
2010-01-20 |
2011-11-16 |
Pronova Biopharma Norge As |
Salicylate fatty acid derivatives
|
EP2542060B1
(en)
*
|
2010-03-04 |
2019-10-02 |
Amarin Pharmaceuticals Ireland Limited |
Compositions for treating and/or preventing cardiovascular disease
|
US9216224B2
(en)
|
2010-03-05 |
2015-12-22 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid COX inhibitor derivatives and their uses
|
RS58335B1
(sr)
|
2010-03-11 |
2019-03-29 |
Kempharm Inc |
Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
|
US20130045939A1
(en)
*
|
2010-03-19 |
2013-02-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid macrolide derivatives and their uses
|
CA2805572A1
(en)
*
|
2010-07-16 |
2012-01-19 |
Martin Hegen |
Modified single domain antigen binding molecules and uses thereof
|
EP3412279B1
(en)
|
2010-09-24 |
2021-02-17 |
The Brigham and Women's Hospital, Inc. |
Nanostructured gels capable of controlled release of encapsulated agents
|
US20140127289A1
(en)
|
2010-11-29 |
2014-05-08 |
Armarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
JP2014505679A
(ja)
*
|
2010-12-21 |
2014-03-06 |
ネステク ソシエテ アノニム |
変形性関節症の予防及び治療のための方法及び組成物
|
KR102162901B1
(ko)
*
|
2011-09-29 |
2020-10-08 |
피엘엑스 옵코 인코포레이티드 |
위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
US20130131170A1
(en)
|
2011-11-07 |
2013-05-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
EP2800469B1
(en)
|
2012-01-06 |
2021-08-25 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
|
DK3363433T3
(da)
|
2012-06-29 |
2021-03-08 |
Amarin Pharmaceuticals Ie Ltd |
Fremgangsmåder til reduktion af risikoen for en kardiovaskulær begivenhed i et individ i statinbehandling ved anvendelse af eicosapentaensyreetylester
|
US20150265566A1
(en)
|
2012-11-06 |
2015-09-24 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
BR112016014611A8
(pt)
|
2013-12-24 |
2023-05-09 |
Univ Virginia Commonwealth |
Usos de sulfatos de colesterol oxigenados (ocs)
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
US10172818B2
(en)
|
2014-06-16 |
2019-01-08 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
US9603869B2
(en)
|
2015-05-22 |
2017-03-28 |
University Of South Florida |
Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders
|
EP3359128A1
(en)
|
2015-10-08 |
2018-08-15 |
The Brigham and Women's Hospital, Inc. |
Stabilized assembled nanostructures for delivery of encapsulated agents
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
EP3452094B1
(en)
|
2016-05-06 |
2021-11-17 |
The Brigham and Women's Hospital, Inc. |
Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
|
WO2018144991A1
(en)
|
2017-02-03 |
2018-08-09 |
The Brigham And Women's Hospital, Inc. |
Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
|
AU2018266131B2
(en)
|
2017-05-08 |
2021-07-29 |
Alivio Therapeutics, Inc. |
Formulation of nanostructured gels for increased agent loading and adhesion
|
US10966951B2
(en)
|
2017-05-19 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject having reduced kidney function
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
PT4056176T
(pt)
|
2018-09-24 |
2024-05-27 |
Amarin Pharmaceuticals Ie Ltd |
Métodos de redução do risco de eventos cardiovasculares num indivíduo
|
AU2021244695A1
(en)
|
2020-03-26 |
2022-11-10 |
Plx Opco Inc. |
Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same
|
KR20240012390A
(ko)
|
2021-04-21 |
2024-01-29 |
애머린 파마슈티칼스 아일랜드 리미티드 |
심부전의 위험을 감소시키는 방법
|